WAM
MDCXW

Warberg Asset Management’s Medicus Pharma Warrant MDCXW Stock Holding History

Warberg Asset Management’s Portfolio MDCXW Stock Details MDCXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,203
Closed -$12.4K – 225
2025
Q3 		$12.4K Sell
17,203
-42,408
-71% -$36.5K ﹤0.01% 167
2025
Q2 		$52.7K Sell
59,611
-5,408
-8% -$5.75K 0.01% 133
2025
Q1 		$45.5K Buy
65,019
+37,549
+137% +$38.9K 0.01% 133
2024
Q4 		$18K Buy
+27,470
New +$17.6K ﹤0.01% 154

Other funds holding MDCXW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Warberg Asset Management's MDCXW Position: Q4 2025 in Review

Warberg Asset Management sold out of Medicus Pharma Warrant (MDCXW) in Q4 2025, closing a stake of 17,203 shares — an estimated $12.4K sold.

Warberg Asset Management first reported a position in MDCXW in Q4 2024 and held it in 4 quarters. The position peaked at $52.7K in Q2 2025. 5 funds tracked by Wall St. Rank hold MDCXW as of Q4 2025.

  • Warberg Asset Management reported no remaining Medicus Pharma Warrant position as of Q4 2025 after selling out during the quarter.
  • Warberg Asset Management sold 17,203 Medicus Pharma Warrant shares in Q4 2025, an estimated $12.4K.
  • Warberg Asset Management first reported a position in Medicus Pharma Warrant in Q4 2024 and held it in 4 quarters.
  • Warberg Asset Management's Medicus Pharma Warrant position peaked at $52.7K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Medicus Pharma Warrant as of Q4 2025.

Based on Warberg Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.